IL-1β is clinically relevant in RCC, because high intratumoral IL-1β in human renal tumors has been associated with increased MDSC accumulation [35] and poor survival (thehumanproteinatlas.org, p <0.001). The gene discussed is IL1B; the disease is renal cell carcinoma.